RxDoctor Payments Data

Aleksandr Kurbanov, MD

Surgery · West Springfield, MANPI 1033100565

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $623 of the $875 with a category attached, or 71.2%. Every reported general payment came from a single manufacturer, Bard Peripheral Vascular, Inc.. That places this record below the midpoint for surgery clinicians in MA, where the typical reported total is $1,048.

$875in general payments, 2019–2025

Across 6 payments — averaging $145.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$875
$90,991in research payments, 2019–2025

Across 7 payments — averaging $12,999 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$62K
  • Humacyte Global, Inc.$29K

What the payments were for

  • Travel & lodging$62371%
  • Food & beverage$25229%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bard Peripheral Vascular, Inc.6$875

How this compares

$875 in reported general payments places this provider in the 45th percentile of 694 surgery providers in Massachusetts.

See all surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$313,330
Medicare patients
219
Services billed
5,550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl22$2,754
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$96

Paid to pharmacies, not to this prescriber.

Other surgery in West Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →